Literature DB >> 7537266

The c-jun proto-oncogene down-regulates the rat alpha-fetoprotein promoter in HepG2 hepatoma cells without binding to DNA.

B Bois-Joyeux1, M Denissenko, H Thomassin, S Guesdon, R Ikonomova, D Bernuau, G Feldmann, J L Danan.   

Abstract

The effects of a phorbol ester (TPA) and of members of the Jun and Fos oncoprotein family on the activity of the rat alpha-fetoprotein (AFP) promoter were checked by using transient expression experiments in HepG2 hepatoma cells. TPA blocked the activity of the rat AFP promoter in a dose-dependent manner. Overexpression of c-Jun specifically repressed the rat AFP promoter but not the albumin promoter. JunB and JunD were poorer inhibitors. c-Fos expression did not potentiate the negative effect of Jun. The Jun-induced repression does not require binding of c-Jun to the AFP promoter. DNase 1 footprinting experiments did not display any high affinity binding site for Jun on the AFP promoter. Integrity of the c-Jun DNA binding domain is not required for the c-Jun protein to block the AFP promoter. The N-terminal part of Jun, which contains the activating domain, is responsible for the repression as shown by using Jun-Gal4 chimera. Jun likely exerts its negative control on the AFP promoter via protein-protein interactions with a not yet identified trans-activating factor within the -134 to +6 region or with a component of the general machinery of transcription. Jun proteins can thus be key intermediates in regulatory cascades which result in the differential modulation of the AFP and albumin gene expression in the course of liver development and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537266     DOI: 10.1074/jbc.270.17.10204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family.

Authors:  L Galarneau; J F Paré; D Allard; D Hamel; L Levesque; J D Tugwood; S Green; L Bélanger
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Modulation of MLC-2v gene expression by AP-1: complex regulatory role of Jun in cardiac myocytes.

Authors:  S K Goswami; S Shafiq; M A Siddiqui
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

3.  Hepatocyte nuclear factor-6 stimulates transcription of the alpha-fetoprotein gene and synergizes with the retinoic-acid-receptor-related orphan receptor alpha-4.

Authors:  Habib Nacer-Cherif; Brigitte Bois-Joyeux; Guy G Rousseau; Frédéric P Lemaigre; Jean-Louis Danan
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

4.  Molecular Mechanisms Underlying the Regulation of the MFG-E8 Gene Promoter Activity in Physiological and Inflammatory Conditions.

Authors:  Xiao Wang; Heng-Fu Bu; Shirley X L Liu; Isabelle G De Plaen; Xiao-Di Tan
Journal:  J Cell Biochem       Date:  2015-09       Impact factor: 4.429

5.  Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the predominant isoform of the nuclear receptor RORalpha in the liver and is up-regulated by hypoxia in HepG2 human hepatoma cells.

Authors:  Caroline Chauvet; Brigitte Bois-Joyeux; Jean-Louis Danan
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver.

Authors:  Zhifang Xie; Hai Zhang; Wenwei Tsai; Ye Zhang; Yu Du; Jigen Zhong; Claude Szpirer; Minghua Zhu; Xuetao Cao; Michelle Craig Barton; Michael J Grusby; Weiping J Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

7.  The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1.

Authors:  Caroline Chauvet; Brigitte Bois-Joyeux; Edurne Berra; Jacques Pouyssegur; Jean-Louis Danan
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

8.  ZBTB20 is a sequence-specific transcriptional repressor of alpha-fetoprotein gene.

Authors:  Hai Zhang; Dongmei Cao; Luting Zhou; Ye Zhang; Xiaoqin Guo; Hui Li; Yuxia Chen; Brett T Spear; Jia-Wei Wu; Zhifang Xie; Weiping J Zhang
Journal:  Sci Rep       Date:  2015-07-15       Impact factor: 4.379

9.  A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma.

Authors:  Agnès Marchio; Stéphane Bertani; Teresa Rojas Rojas; Franco Doimi; Benoît Terris; Eric Deharo; Anne Dejean; Eloy Ruiz; Pascal Pineau
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.